LAB compared with ADPT: revenue, margins and what each company keeps, and the suppliers and customers both name

LABStandard Biotools Inc.

Mkt capRevenueRevenue

ADPTAdaptive Biotechnologies Corp

Mkt capRevenueRevenue

Compare

LABStandard Biotools Inc.

ADPTAdaptive Biotechnologies Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LAB

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±41.1%▲+2.04%×0.05

Q1 FY26±44.5%▼−1.07%×0.02

Feb 25 '26±22.9%▲+1.74%×0.07

Jan 30 '26±18.1%▼−0.71%×0.04

ADPT

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±15.2%▲+7.18%×0.47

Q1 FY26±16.2%▲+4.72%×0.29

= impliedLAB realized, solidADPT realized, hatchedOne scale, both sides: full bar = 45%× = |realized| ÷ impliedSource: market data

Feb 6 '26

±13.4%

▼−4.25%

×0.32

Jan 12 '26±13.5%▲+15.86%×1.18

LABStandard Biotools Inc.

0.62· pre 0.61· delayed

Mkt cap$239.5MRevenue$20MQ2 FY26Revenue$65MFY25

ADPTAdaptive Biotechnologies Corp

26.62· pre 26.65

Pre-marketSep 2 '83

Mkt cap$4.3BRevenue$72MQ2 FY26Revenue$277MFY25

Compare

Pre-marketSep 2 '83

LABStandard Biotools Inc.

ADPTAdaptive Biotechnologies Corp

0.62pre 0.61delayed

Price

26.62pre 26.65

$239.5M

Mkt cap

$4.3B

Q2 FY26$20M

Revenue

$72MQ2 FY26

FY25$65M

Revenue

$277MFY25

LAB0.62vsADPT26.62Pre-marketSep 2 '83